journal article·2022-12Open access

Structural control of self-assembled peptide nanostructures to develop peptide vesicles for photodynamic therapy of cancer

Soo hyun Kwon, Donghyun Lee, Hyoseok Kim, You-jin Jung, Heebeom Koo, Yong-beom Lim

Abstract

Vesicles such as liposomes, polymersomes, and exosomes have been widely used as drug delivery carriers; however, peptide vesicles (peptidesomes) despite their potential utility are far less well developed. Peptidesomes are distinctive because peptides play dual roles as a self-assembly building block and a bioactive functional unit. In order for peptidesomes to become successful nanodrugs, the issues related to differences in nanostructural properties between in vitro and in vivo conditions should be addressed. Here, we delineate a multivariate approach to feedback control the structures of peptide building blocks, nanoparticle size, drug loading process, nanoparticle aggregation, cytotoxicity, cell targeting capability, endosome disruption function, protease resistance, and in vivo performance, which eventually enabled the successful development of a highly efficacious peptidesome for in vivo cancer therapy. This study lays the groundwork for the successful in vivo translation of peptide nanodrugs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (37)

Show source-provided references
1. Multicomponent peptide assemblies10.1039/C8CS00115D ↗
2. Self-assembling peptide semiconductors10.1126/science.aam9756 ↗
3. Nanomechanics of functional and pathological amyloid materials10.1038/nnano.2011.102 ↗
4. Structural, nanomechanical, and computational characterization of D,L-cyclic peptide assemblies10.1021/acsnano.5b00672 ↗
5. 3D2 self-assembling janus peptide dendrimers with tailorable supermultivalency10.1002/adfm.201808020 ↗
6. Engineered nanoparticles for drug delivery in cancer therapy10.1002/anie.201403036 ↗
7. Biodegradable polymersomes with structure inherent fluorescence and targeting capacity for enhanced photo-dynamic therapy10.1002/anie.202105103 ↗
8. Extracellular vesicles as a next-generation drug delivery platform10.1038/s41565-021-00931-2 ↗
9. Long circulating photoactivable nanomicelles with tumor localized activation and ROS triggered self-accelerating drug release for enhanced locoregional chemo-photodynamic therapy10.1016/j.biomaterials.2019.119702 ↗
10. Photo- and thermoresponsive polymersomes for triggered release10.1002/anie.201206531 ↗
11. Fabrication of multicomponent multivesicular peptidoliposomes and their directed cytoplasmic delivery10.1021/acsmacrolett.7b00064 ↗
12. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery10.1074/jbc.M007540200 ↗
13. Arginine-rich cell-penetrating peptides10.1016/j.febslet.2009.11.046 ↗
14. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs10.1038/s41565-019-0591-y ↗
15. Chemistry. Nanomaterials for drug delivery10.1126/science.1219657 ↗
16. Israelachvili · 2011
17. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings10.1016/S0169-409X(00)00129-0 ↗
18. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells10.1562/0031-8655(2002)075<0140:IVAIVE>2.0.CO;2 ↗
19. Optimized combination of photodynamic therapy and chemotherapy using gelatin nanoparticles containing tirapazamine and pheophorbide a10.1021/acsami.1c02316 ↗
20. Enforcing extended porphyrin J-aggregate stacking in covalent organic frameworks10.1021/jacs.8b08088 ↗
21. The effect of H- and J-aggregation on the photophysical and photovoltaic properties of small thiophene–pyridine–DPP molecules for bulk-heterojunction solar cells10.1002/adfm.201605779 ↗
22. pH-dependent in-cell self-assembly of peptide inhibitors increases the anti-prion activity while decreasing the cytotoxicity10.1021/acs.biomac.6b01816 ↗
23. Comparative study on the in vitro cytotoxicity of linear, dendritic, and hyperbranched polylysine analogues10.1021/bm300930j ↗
24. Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes10.1021/mp3007117 ↗
25. RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells10.1002/adma.201003944 ↗
26. A cyclic RGD-coated peptide nanoribbon as a selective intracellular nanocarrier10.1039/b802470g ↗
27. Zwitterionic peptide clock mimics protein surface for protein protection10.1002/anie.202004995 ↗
28. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy10.1021/ja0680257 ↗
29. Effects of ionic strength on the colloidal stability and interfacial assembly of hydrophobic ethyl cellulose nanoparticles10.1021/acs.langmuir.5b01857 ↗
30. Anisotropic electrostatic screening of charged colloids in nematic solvents10.1126/sciadv.abd0662 ↗
31. Influence of ionic strength on hydrophobic interactions in water: dependence on solute size and shape10.1021/acs.jpcb.0c06399 ↗
32. Structural and conformational dynamics of self-assembling bioactive beta-sheet peptide nanostructures decorated with multivalent RNA-binding peptides10.1021/ja307493t ↗
33. Mechanisms of protein stabilization and prevention of protein aggregation by glycerol10.1021/bi900649t ↗
34. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review10.1016/S0168-3659(99)00248-5 ↗
35. Biological relevance of RGD-integrin subtype-specific ligands in cancer10.1002/cbic.202000626 ↗
36. Rhamnolipid nanoparticles for in vivo drug delivery and photodynamic therapy10.1016/j.nano.2019.03.015 ↗
37. Rapid profiling of peptide stability in proteolytic environments10.1021/ac802324f ↗